Works matching IS 17534658 AND DT 2011 AND VI 5 AND IP 3

Results: 7

NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 3, p. 163, doi. 10.1177/1753465811406001

By:

Vogelmeier, Claus;
Banerji, Donald

Publication type:

Article

Nasal obstruction as a drug side effect.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 3, p. 175, doi. 10.1177/1753465811403348

By:

Cingi, Cemal;
Ozdoganoglu, Tunis;
Songu, Murat

Publication type:

Article

COPD: a multifactorial systemic disease.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 3, p. 217, doi. 10.1177/1753465811400490

By:

Huertas, Alice;
Palange, Paolo

Publication type:

Article

The role of monoclonal antibodies in the treatment of severe asthma.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 3, p. 183, doi. 10.1177/1753465811400489

By:

Tourangeau, Louanne M.;
Kavanaugh, Arthur;
Wasserman, Stephen I.

Publication type:

Article

The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 3, p. 207, doi. 10.1177/1753465811398372

By:

Berim, Ilya;
Sethi, Sanjay

Publication type:

Article

The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 3, p. 195, doi. 10.1177/1753465810397693

By:

Gessler, Tobias;
Seeger, Werner;
Schmehl, Thomas

Publication type:

Article

Antifungal medication is efficient in the treatment of sarcoidosis.

Published in:

Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 3, p. 157, doi. 10.1177/1753465811401648

By:

Terčelj, Marjeta;
Salobir, Barbara;
Zupancic, Mirjana;
Rylander, Ragnar

Publication type:

Article